Esta es una clase de medicamentos que ayuda a controlar los niveles de azcar en la sangre en la diabetes tipo 2, pero tambin puede ser utilizada para tratar la obesidad
Treatment is administered through small subcutaneous injections in minutes
According to the Gallup National Health and Well-Being Index, 11% of Americans are currently using a GLP-1, a drug commonly prescribed for obesity or diabetes
The results indicate that focusing on the METTL3/HMGB1 pathway might provide a new therapeutic approach for treating KOA [113]
The FDAs warning letters come as the shortage status of Eli Lillys tirzepatidemarketed as Mounjaro for type 2 diabetes and as Zepbound for chronic weight managementremains in limbo, enabling compounding pharmacies to legally continue making versions of the drugs
doi: 10.3389/fcimb.2024.1426340 Received 01 May 2024 Accepted 29 May 2024 Published 13 August 2024 Volume 14 - 2024 Edited by Rongrong Ma, Ningbo University, China Reviewed by Jianfei Lu, Ningbo University, China Yongxiang Yu, Chinese Academy of Fishery Sciences (CAFS), China Hui Xue, Freshwater Fisheries Research Institute of Jiangsu Province, China Updates Copyright 2024 Su, Gao, Shu, Cai, Fang, Lei, Li and Hu